Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,889–2,896 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Neurocrine Biosciences Inc. TAK-041 / NBI-1065846 Anhedonia in depression Phase 2 Data Released Oral Psychiatric
Neurocrine Biosciences Inc. TAK-653 / NBI-1065845 Major Depressive Disorder (MDD) Phase 2 Data Released Oral Psychiatric
Neurocrine Biosciences Inc. TAK-831 / Luvadaxistat (NBI-1065844) Negative symptoms of schizophrenia Phase 2 Trial Discontinued Oral Psychiatric
Neurocrine Biosciences Inc. ACT-709478 (NBI-827104) - (STEAMBOAT) Pediatric epilepsy Phase 2 Data Released Oral Neurology
Neurocrine Biosciences Inc. NBI-921352 SCN8A developmental and epileptic encephalopathy (SCN8A-DEE) Phase 2 Trial Discontinued Oral Neurology
Neurocrine Biosciences Inc. INGREZZA Tourette syndrome - adults Phase 2 Withdrawn oral Neurology
NeuroSense Therapeutics Ltd. PrimeC - (PARADIGM) Amyotrophic Lateral Sclerosis (ALS) Phase 2b Data Released Oral Neurology
NeuroSense Therapeutics Ltd. PrimeC - (RoAD) Alzheimer's disease (AD) Phase 2 Ongoing Oral Neurology